These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33797585)

  • 1. TDP-43 interacts with pathological τ protein in Alzheimer's disease.
    Tomé SO; Gomes LA; Li X; Vandenberghe R; Tousseyn T; Thal DR
    Acta Neuropathol; 2021 May; 141(5):795-799. PubMed ID: 33797585
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein studies try to puzzle out Alzheimer's tangles.
    Roush W
    Science; 1995 Feb; 267(5199):793-4. PubMed ID: 7846523
    [No Abstract]   [Full Text] [Related]  

  • 3. Tau protein in Alzheimer’s disease.
    Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):607. PubMed ID: 21827396
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel perspective on tau in Alzheimer's disease.
    Bonda DJ; Castellani RJ; Zhu X; Nunomura A; Lee HG; Perry G; Smith MA
    Curr Alzheimer Res; 2011 Sep; 8(6):639-42. PubMed ID: 21605042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimalistic in vitro systems for investigating tau pathology.
    Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K
    J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3R and 4R tau isoforms in paired helical filaments in Alzheimer's disease.
    Hasegawa M; Watanabe S; Kondo H; Akiyama H; Mann DM; Saito Y; Murayama S
    Acta Neuropathol; 2014 Feb; 127(2):303-5. PubMed ID: 24212601
    [No Abstract]   [Full Text] [Related]  

  • 7. Are tangles as toxic as they look?
    Spires-Jones TL; Kopeikina KJ; Koffie RM; de Calignon A; Hyman BT
    J Mol Neurosci; 2011 Nov; 45(3):438-44. PubMed ID: 21638071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias.
    Trojanowski JQ; Lee VM
    Ann N Y Acad Sci; 1994 Dec; 747():92-109. PubMed ID: 7847694
    [No Abstract]   [Full Text] [Related]  

  • 9. Alzheimer's disease. Tangle disentanglement.
    Beyreuther K; Masters CL
    Nature; 1996 Oct; 383(6600):476-7. PubMed ID: 8849716
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease.
    Brion JP
    J Alzheimers Dis; 2006; 9(3 Suppl):177-85. PubMed ID: 16914857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease].
    Takeda M; Kudo T; Taniguchi N; Nishimura T
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):169-72. PubMed ID: 8648891
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 14. Sources of extracellular tau and its signaling.
    Avila J; Simón D; Díaz-Hernández M; Pintor J; Hernández F
    J Alzheimers Dis; 2014; 40 Suppl 1():S7-S15. PubMed ID: 24531154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau as a therapeutic target for Alzheimer's disease.
    Boutajangout A; Sigurdsson EM; Krishnamurthy PK
    Curr Alzheimer Res; 2011 Sep; 8(6):666-77. PubMed ID: 21679154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration.
    Nakamori M; Takahashi T; Yamazaki Y; Kurashige T; Yamawaki T; Matsumoto M
    Neuroreport; 2012 Oct; 23(15):867-72. PubMed ID: 22968343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
    Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P
    J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of tau self-aggregation and neurotoxicity.
    Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
    Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
    J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.